会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明申请
    • MOLECULES OF THE NBS/LRR PROTEIN FAMILY AND USES THEREOF
    • NBS / LRR蛋白家族的分子及其用途
    • WO0183753A3
    • 2002-05-23
    • PCT/US0114283
    • 2001-05-03
    • MILLENNIUM PHARM INCBERTIN JOHN
    • BERTIN JOHN
    • C07K14/47C12N15/12C07K16/18C12N15/10C12N15/62C12Q1/68G01N33/53
    • C07K14/47C07K2319/00
    • Novel NBS-2, NBS-3, NBS-4, and NBS-5 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated NBS-2, NBS-3, NBS-4, and NBS-5 proteins, the invention further provides NBS-2, NBS-3, NBS-4, and NBS-5 fusion proteins, antigenic peptides and anti-NBS-2, anti-NBS-3, anti-NBS-4, and anti-NBS-5 antibodies. The invention also provides NBS-2, NBS-3, NBS-4, and NBS-5 nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a NBS-2, NBS-3, NBS-4, or NBS-5 gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
    • 公开了新型NBS-2,NBS-3,NBS-4和NBS-5多肽,蛋白质和核酸分子。 除了分离的NBS-2,NBS-3,NBS-4和NBS-5蛋白外,本发明还提供NBS-2,NBS-3,NBS-4和NBS-5融合蛋白,抗原肽和抗 - NBS-2,抗NBS-3,抗NBS-4和抗NBS-5抗体。 本发明还提供了NBS-2,NBS-3,NBS-4和NBS-5核酸分子,含有本发明的核酸分子的重组表达载体,已经引入了表达载体的非宿主细胞 NBS-2,NBS-3,NBS-4或NBS-5基因已被引入或破坏的转基因动物。 还提供利用本发明组合物的诊断,筛选和治疗方法。
    • 13. 发明申请
    • MOLECULES OF THE CARD-RELATED PROTEIN FAMILY AND USES THEREOF
    • 相关蛋白家族的分子及其用途
    • WO0140468A3
    • 2002-01-17
    • PCT/US0032716
    • 2000-12-01
    • MILLENNIUM PHARM INCBERTIN JOHN
    • BERTIN JOHN
    • C07K14/47C12N15/12C07K16/18C12Q1/68G01N33/53G01N33/68
    • C07K14/4747
    • Novel CARD-9, CARD-10, or CARD-11 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated CARD-9, CARD-10, or CARD-11 proteins, the invention further provides CARD-9, CARD-10, or CARD-11, fusion proteins, antigenic peptides and anti-CARD-9, CARD-10, or CARD-11 antibodies. The invention also provides CARD-9, CARD-10, or CARD-11 nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a CARD-9, CARD-10, or CARD-11 gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
    • 公开了新型CARD-9,CARD-10或CARD-11多肽,蛋白质和核酸分子。 除了分离的CARD-9,CARD-10或CARD-11蛋白,本发明还提供CARD-9,CARD-10或CARD-11,融合蛋白,抗原肽和抗CARD-9 CARD-10 或CARD-11抗体。 本发明还提供CARD-9,CARD-10或CARD-11核酸分子,含有本发明的核酸分子的重组表达载体,已经引入了表达载体的宿主细胞和非人转基因动物,其中 CARD-9,CARD-10或CARD-11基因已被引入或破坏。 还提供利用本发明组合物的诊断,筛选和治疗方法。
    • 15. 发明申请
    • NOVEL MOLECULES OF THE CARD-RELATED PROTEIN FAMILY AND USES THEREOF
    • 相关蛋白家族的新分子及其用途
    • WO0100826A3
    • 2001-11-29
    • PCT/US0017691
    • 2000-06-28
    • MILLENNIUM PHARM INCBERTIN JOHN
    • BERTIN JOHN
    • C07K14/47C12N15/12C12Q1/68C07K16/18C12N5/10G01N33/50G01N33/53
    • C12Q1/6897C07K14/4702
    • Novel CARD-3, CARD-4L, CARD-4S, CARD-4Y, CARD-4Z, CARD-5, and CARD-6 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated CARD-3, CARD-4L, CARD-4S, CARD-4Y, CARD-4Z, CARD-5, and CARD-6 proteins, and the invention further provides CARD-3, CARD-4L, CARD-4S, CARD-4Y, CARD-4Z, CARD-5, and CARD-6 fusion proteins, antigenic peptides and anti-CARDS-3, anti-CARD-4L and anti-CARD-4S, anti-CARD-4Y, anti-CARD-4Z, anti-CARDS-5, and anti-CARD-6 antibodies. The invention also provides CARD-3, CARD-4L, CARD-4S, CARD-4Y, CARD-4Z, CARD-5, and CARD-6 nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a CARD-3, CARD-4L, CARD-4S, CARD-4Y, CARD-4Z, CARD-5, and CARD-6 gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
    • 公开了新型CARD-3,CARD-4L,CARD-4S,CARD-4Y,CARD-4Z,CARD-5和CARD-6多肽,蛋白质和核酸分子。 除了分离的CARD-3,CARD-4L,CARD-4S,CARD-4Y,CARD-4Z,CARD-5和CARD-6蛋白外,本发明还提供CARD-3,CARD-4L,CARD-4S CARD-4Y,CARD-4Z,CARD-5和CARD-6融合蛋白,抗原肽和抗CARDS-3,抗CARD-4L和抗CARD-4S,抗CARD-4Y,抗CARD -4Z,抗CARDS-5和抗CARD-6抗体。 本发明还提供CARD-3,CARD-4L,CARD-4S,CARD-4Y,CARD-4Z,CARD-5和CARD-6核酸分子,含有本发明核酸分子的重组表达载体,宿主细胞 其中引入了表达载体和已经引入了CARD-3,CARD-4L,CARD-4S,CARD-4Y,CARD-4Z,CARD-5和CARD-6基因的非人转基因动物,或 破坏。 还提供利用本发明组合物的诊断,筛选和治疗方法。
    • 16. 发明申请
    • NOVEL MOLECULES OF THE CARD-RELATED PROTEIN FAMILY AND USES THEREOF
    • 相关蛋白家族的新分子及其用途
    • WO9940102A9
    • 2001-09-20
    • PCT/US9902544
    • 1999-02-05
    • MILLENNIUM PHARM INCBERTIN JOHN
    • BERTIN JOHN
    • G01N33/50C07K14/47C07K16/18C12N1/15C12N1/19C12N1/21C12N5/10C12N15/09C12P21/02C12Q1/02C12Q1/68G01N33/15C07H21/02C07H21/04C07K5/00C12N15/11
    • C12Q1/6897C07K14/4702
    • Novel CARD-3, CARD-4L, CARD-4S, CARD-4Y, CARD-4Z, and murine CARD-4L polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated CARD-3, CARD-4L, CARD-4S, CARD-4Y, CARD-4Z, and murine CARD-4L proteins, and the invention further provides CARD-3, CARD-4L, CARD-4S, CARD-4Y, CARD-4Z, and murine CARD-4L fusion proteins, antigenic peptides and anti-CARD-3, anti-CARD-4L and anti-CARD-4S, anti-CARD-4Y, anti-CARD-4Z, and anti-murine CARD-4L antibodies. The invention also provides CARD-3, CARD-4L, CARD-4S, CARD-4Y, CARD-4Z, and murine CARD-4L nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a CARD-3, CARD-4L, CARD-4S, CARD-4Y, CARD-4Z, and murine CARD-4L gene has been introduced or disrupted. The invention further provides CARD-3 and CARD-4 target proteins that bind to CARD-3 or CARD-4 and allelic variants of human CARD-4. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
    • 公开了新型CARD-3,CARD-4L,CARD-4S,CARD-4Y,CARD-4Z和鼠CARD-4L多肽,蛋白质和核酸分子。 除了分离的CARD-3,CARD-4L,CARD-4S,CARD-4Y,CARD-4Z和鼠CARD-4L蛋白之外,本发明还提供CARD-3,CARD-4L,CARD-4S,CARD- 4Y,CARD-4Z和鼠CARD-4L融合蛋白,抗原肽和抗CARD-3,抗CARD-4L和抗CARD-4S,抗CARD-4Y,抗CARD-4Z和抗 - 鼠CARD-4L抗体。 本发明还提供CARD-3,CARD-4L,CARD-4S,CARD-4Y,CARD-4Z和鼠CARD-4L核酸分子,含有本发明的核酸分子的重组表达载体, 已经引入了表达载体,其中引入或破坏CARD-3,CARD-4L,CARD-4S,CARD-4Y,CARD-4Z和鼠CARD-4L基因的非人转基因动物。 本发明还提供结合CARD-3或CARD-4的CARD-3和CARD-4靶蛋白以及人CARD-4的等位基因变体。 还提供利用本发明组合物的诊断,筛选和治疗方法。